Table 3.
Annual Incidence and Prevalence of Urinary Incontinence in Patients With AD.
Annual incidence of urinary incontinence in AD | |
All patients with AD | 6.2% |
Rivastigmine | 7.8% |
Donepezil | 5.8% |
Galantamine | 2.9% |
Memantine | 1.4% |
Urinary incontinence prevalence in AD | |
All patients with AD | 4.2% |
Rivastigmine | 3.4% |
Donepezil | 4.8% |
Galantamine | 5.6% |
Memantine | 4.4% |
Abbreviation: AD, Alzheimer’s disease.